等离子体介导降解对纤维解和组织等离子体激活剂扩散的影响
Brittany E Bannish1, Bradley Paynter1, Rebecca A Risman2
1University of Central Oklahoma, Department of Mathematics and Statistics, Edmond, Oklahoma.
Biophysical journal
|February 15, 2024
概括
通过等离子体介导的纤维素降解会影响组织等离子体激活剂 (tPA) 扩散,影响纤维素分解速率. 这项研究揭示了tPA释放机制如何影响凝块溶解速度.
科学领域:
- 生物物理学的生物物理.
- 生物化学 生物化学
- 计算生物学 计算生物学
背景情况:
- 纤维解析是血液凝块溶解的关键过程.
- 组织等离子体激活剂 (tPA) 是纤维解中的关键酶.
- 了解纤维素凝块中的tPA动态对于治疗开发至关重要.
研究的目的:
- 为了研究等离子体介导的纤维素降解对tPA扩散和纤维素分解的影响.
- 模拟tPA从纤维素纤维释放的机制,包括动力和强制解结.
- 为了将tPA与纤维素和纤维素降解产物 (FDP) 的结合亲和力与溶解速率相关联.
主要方法:
- 修改一个三维的纤维素分解多尺度模型.
- 通过简单的动力解结和强制解结来模拟tPA释放.
- 基于其与纤维素或FDPs结合的tPA扩散动态的分析.
- 模型预测与实验室实验结果的比较.
主要成果:
- 等离子素可以增加有效的tPA扩散,当tPA与扩散到凝块中的小纤维素碎片结合时.
- 等离子素可以降低有效的tPA扩散,当tPA与扩散沿着凝块的大型FDP结合时.
- 当tPA与扩散到凝块中的纤维素碎片结合时,溶解速度最快.
- 具有较低解离常数的tPA突变体表现出较慢的溶解,而具有较高常数的突变体表现出更快的溶解.
结论:
- 纤维素降解产物 (FDP) 可以扩散成凝块,影响tPA的移动性.
- 从纤维素中强制解脱tPA会产生FDP混合物,影响tPA扩散模式.
- tPA结合亲和力是纤维解效率的关键决定因素,对抗血栓治疗有影响.
相关概念视频
Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K


